Watch Amazon, Dexcom, Corteva, and Coinbase
After Amazon’s Q2 results, AMZN shares rose 17% last week. Revenue grew 20% Y/Y to $200.6B, with AWS up 36.7% Y/Y to $42.2B. Dexcom (DXCM) hit a 52-week high on Q2 results and a 2026 revenue forecast of $5.18B to $5.25B. Corteva (CTVA) fell ~12% despite guidance; Coinbase (COIN) dropped after Q2 GAAP EPS of -$1.36 and Q3 subscription/services revenue up to $580B.
How this was made
The 30-second read
Why it matters
The trading focus is on how reported revenue growth, forecast ranges, and GAAP EPS outcomes translated into sharp price moves, especially for COIN and CTVA.
Market read
This is a post-earnings reaction roundup with specific revenue/EPS and guidance figures, but it does not introduce a brand-new catalyst beyond the already-referenced earnings.
What to watch
The piece does not provide consensus estimates, margin details beyond a general AI demand claim, or segment-level drivers for CTVA and COIN, limiting conviction on magnitude and duration.
Background
A multi-stock watchlist summarizes recent earnings reactions for Amazon, Dexcom, Corteva, and Coinbase.
Ticker impact
Amazon shares gained 17% last week after Q2 revenue rose 20% Y/Y to $200.6B, with AWS up 36.7% Y/Y.
Near-term bias to follow-through given the cited revenue and AWS growth figures.
The article cites specific Q2 growth rates and frames margins benefiting from multi-modal AI, which can sustain sentiment beyond the technical bounce.
Dexcom traded to a 52-week high after Q2 results and a 2026 revenue forecast of $5.18B to $5.25B.
Potential continuation if investors treat the forecast range as credible and supportive of estimates.
The newest concrete facts are the Q2 reaction and the specific revenue forecast range, both directly tied to the stock move described.
Corteva fell about 12% after reporting Q2 revenue of $6.38B (-2.4% Y/Y) and non-GAAP EPS of $2.30.
Choppy to downside-biased until the market digests the guidance increase versus the weaker top line.
The article provides the key downside datapoints (revenue and EPS) and notes guidance was increased, implying mixed signals.
Coinbase dropped 10.59% after earnings, with Q2 GAAP EPS of -$1.36 and Q3 subscription and services revenue up to $580M.
Near-term pressure risk if transaction-volume concerns outweigh the reported volume growth.
The newest facts are the post-earnings price drop, GAAP EPS miss, and the Q3 revenue cap, all directly tied to the described selloff.
Market effects
AI demand narrative supports cloud software and infrastructure sentiment; medical devices and biotech-style guidance sensitivity remains evident; crypto exchange earnings remain tied to trading activity.
Primarily US large-cap and US-listed healthcare and fintech/crypto sentiment.
Crypto volume and exchange revenue sensitivity can spill over to broader digital-asset risk appetite.
Counterpoint
The article frames moves as earnings-driven, but technical breakdowns and rebounds can overreact; guidance increases (CTVA) and volume growth (COIN) may reduce downside follow-through.
Key entities
- public_companyAmazon
Q2 revenue growth and AWS growth cited as drivers of a 17% weekly gain.
- public_companyDexcom
Q2 results and a 2026 revenue forecast range tied to a move to a 52-week high.
- public_companyCorteva
Q2 revenue decline and non-GAAP EPS cited alongside increased guidance.
- public_companyCoinbase Global
Post-earnings drop tied to GAAP EPS and a Q3 revenue range, with crypto-volume concerns discussed.
